MONTREAL, May 30, 2014 /CNW Telbec/ - Aptilon Corporation ("Aptilon" or the "Company") (NEX: APZ.H), reported a net income for the three-month period ended March 31, 2014 of $0.2 million on revenues of $4.8 million compared to a net loss of $0.8 million on revenues of $4.1 million for the three-month period ended March 31, 2013, an improvement of $1 million.
The Company reported an operating income, before net finance expense of $0.7 million for the three-month period ended March 31, 2014 compared to an operating income, before net finance expense of $0.2 million for the three-month period ended March 31, 2013.
During the quarter, the Company continued to improve and expand its data services product offering to consolidate its position as the communication channel of choice for healthcare companies to reach professionals through web and mobile technology.
Complete financial statements and MD&A for the three-month period ended March 31, 2014 are available on SEDAR at www.sedar.com
About Aptilon Corporation
Aptilon enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Top pharmaceutical companies, agencies and respected healthcare organizations have adopted Aptilon's solutions to target, engage and interact with leading healthcare practitioners. For more information, visit www.dmdconnects.com .
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Aptilon Holdings
For further information: